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Drug dispensingAbstract Objective: To assess the compliance of community pharmacies with the regulations that
prohibit the dispensing of prescription-only medications in the absence of a physician prescription
in Saudi Arabia.
Method: A cross-sectional study was conducted in the period between October 2014 and January
2015. A list of 10 prescription-only medications were selected to be studied. 150 community phar-
macies were visited across 6 major regions in Saudi Arabia to assess the prevalence of non-
compliance among community pharmacies. Pharmacies were selected in random and researchers
(disguised as patients) requested to purchase prescription-only medications in the absence of a pre-
scription. Not all medications were purchased at once. Data were recorded per pharmacy, where
pharmacies that approved dispense of the selected drug were scored as non-compliant and the phar-
macies that rejected dispense of the selected drug were scored as compliant. Compliance rate was
calculated per region per drug. Pharmacies based in governmental hospitals were visited in parallel.
A total of 20 were visited. Data and statistical analysis were performed using Statistical Analyses
Software (SAS 9.3).
Results: A total of 150 pharmacies were visited over a period of 3 months. On average, the per-
cent approved dispense of prescription-only drugs across 6 regions in Saudi Arabia is 63% and the
percent rejected dispense is 37% representing a signiﬁcant non-compliance rate regarding the
selected list of medications in this study. The frequency of dispense per medication across 6 major
regions in Saudi Arabia is as follows: Isosorbide dinitrate (86%), Enoxaparin (82%), nitroglycerin
(74%), Propranolol (73%), Verapamil (70%), Warfarin (65%), Methyldopa (64%), Ciprofloxacin
(57%) and Codeine (4%).ations at
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community pharmacies in Saudi Arabia. SauConclusions: Non-compliance of community pharmacies with the law of pharmaceutical practice
is at an alarming rate in the Kingdom of Saudi Arabia and authoritative ﬁgures must intervene to
impede and combat such activities.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In Saudi Arabia, patients perceive community pharmacies as a
ﬁrst line of contact prior to a physician visit, as is the case with
many developing countries (Sabry et al., 2014; Hussain et al.,
2012). This is a concern to the public, in particular, as medica-
tions are dispensed for inappropriate indications (Sabry et al.,
2014). Such practices are threatening to patients’ safety and to
the potential development of drug resistant pathogens, espe-
cially with the uncontrolled dispense of antibiotics (Al-
Ghamdi, 2001; Zowawi et al., 2013). Under the Saudi law, only
licensed pharmacists are allowed to practice the profession of
pharmacy. This law requires pharmacists to dispense drugs
with a valid physician prescription only (Al-Mohamadi
et al., 2013). Despite having a clear law that regulated the dis-
pense of prescription-only medications, several studies have
documented breaches of the current law SA Bawazir, 1992
(Al-Mohamadi et al., 2013).
In 1987, 10 years after the Saudi law of pharmacy practice
was passed, 85.4% of pharmacies in Saudi Arabia dispensed
antibiotics promptly (Al-Mohamadi et al., 2013). In 1992,
the percentage of dispensing prescription drugs without a pre-
scription was 35% (SA Bawazir, 1992), an alarming percentage
after 15 years. The percentage of non-compliance to the law
was as high as 98.9% in 2001 in the Eastern Province, a large
region of Saudi, where only 1 pharmacist out of 88 community
pharmacies surveyed refused to dispense an antibiotic without
a prescription (Al-Ghamdi, 2001) illustrating that the vast
majority of pharmacists do not comply to current pharmaceu-
tical law in Saudi Arabia.
Dispensing medications without a valid prescription can
have devastating consequences in the long run. For instance,
it can impact patient compliance to prescribed medications,
which is a worldwide concern (Al-Ghamdi, 2001; Brown and
Bussell, 2011). It will be more likely that patients do not take
their medications if they do not get the proper diagnosis or
education from a physician; and simply sufﬁce by managing
symptoms with prescription medications from pharmacies.
Yet of more concern is prescription drug abuse, addiction
and overdose, as controlled substances are dispensed without
a valid prescription.
In the present study, we assess the magnitude of pharmacy
compliance with local laws and regulations that govern dis-
pensing of prescription-only drugs in the Kingdom of Saudi
Arabia. These results represent the ﬁrst true reﬂection of the
current situation of pharmacy compliance with appropriate
dispensing practice of prescription-only medications.
2. Method
In the current study, 150 community pharmacies across Saudi
Arabia were randomly selected to assess the magnitude ofri, T.M. et al., Pharmacy Malpractice: T
di Pharmaceutical Journal (2016), httpcompliance/noncompliance across the country The pharmacies
distribution is as follows: Riyadh (36 pharmacies), Jeddah (24
pharmacies), Madinah (20 pharmacies), Hail (15 pharmacies),
Qassim (33 pharmacies) and Sharqiah (22 pharmacies)
(Fig. 1A). All selected cities represent major regions in the
country. The study was performed over a period of 3 months
(between Oct 2014 and Jan 2015). A total of 10 prescription-
only medications for various indications and with a high risk
proﬁle of adverse effects were selected for the study. The
researchers posed as patients and requested to purchase one
or two of the selected medications.
The list of drugs is presented in Table 1. The same requests
were submitted to hospital pharmacies, the government sector,
for comparison between the two settings.
3. Statistical analyses
Descriptive statistics were produced for requested medications.
Surveyed community pharmacies were scored as per their
response to each requested medication. Responses were calcu-
lated as percentage of non-compliance with laws and regula-
tions per drug per region (Figs. 2). Also, we calculated the
overall percentage of non-compliance for each requested drug
(Fig. 3). Data were analyzed using SAS version 9.3. A chi-
square test or Fisher’s exact tests were used to analyze the cat-
egorical data. All statistical tests were conducted with a 2-
tailed alpha of 0.05.
4. Results
4.1. Prevalence of non-compliance with the pharmaceutical
professional standards regarding the dispense of prescription-
only drugs
We assessed the prevalence of noncompliance across major
cities in the Kingdom (Fig. 1A). On average, the percent
approved dispense of prescription-only drugs across 6 regions
in Saudi Arabia is 63% and the percent rejected dispense is
37% (Fig. 1B).
4.2. Percent distribution of approved dispense of prescription-
only drugs across Saudi Arabia
Non-compliance was scored as percentage of approved dis-
pense (Fig. 2) and as percentage of rejected dispense per
region. Across all regions, the only two drugs that were
rejected to be dispensed at some pharmacies are as follows:
Enoxaparin in the regions of Qassim and Sharqiah only and
codeine in the regions of Qassim, Riyadh, Sharqiah and Hail.
Interestingly, the percent of approved dispense was on average
above 50 percent for the remaining 8 drugs (Fig. 2).he rate and prevalence of dispensing high-risk prescription-only medications at
://dx.doi.org/10.1016/j.jsps.2016.10.001
Figure 1 Non-compliance rate with prescription-only medications in Saudi Arabia. (A) Major regions where both community and
hospital based-pharmacies were visited. (B) Overall non-compliance rate with the law of pharmaceutical practice in community
pharmacies in Saudi Arabia. The bars represent the average of approved and rejected rates of dispense for the prescription-only
medications across the major regions in Saudi Arabia. Statistical analysis was performed using the unpaired t test, and error bars represent
the standard deviation among the medications surveyed.
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Table 1 List of requested medications without prescriptions.
Medication
name
Indication
Methyldopa Antihypertension (Zowawi et al., 2013)
Codeine Pain Management (Wolﬀ et al., 1940)
Isosorbide
Dinitrate
Heart Failure (Thadani and Jacob, 2008)
Enoxaparin Antithrombotic (Meneveau, 2009)
Nitroglycerin Stable Angina Pectoris (Todd et al., 1990)
Ciproﬂoxacin Complicated UTI and other infections (Finch,
2000)
Verapamil Antiarrhythmic (Baky and Singh, 1982)
Warfarin Primary and secondary prevention of VTE
(Alquwaizani et al., 2013)
Digoxin Permanent atrial ﬁbrillation (AF), heart failure
and left ventricular dysfunction (Tatlisu et al.,
2015)
Propranolol Antihypertension (Hayton, 1975)
4 T.M. Alshammari et al.4.3. Codeine is the least dispensed prescription-only medication
in Saudi Arabia
We further analyzed the data collected from the major 6
regions in Saudi Arabia to assess which prescription –only
drug is most likely to be dispensed and vice versa. Among
the 10 studied classiﬁed prescription-only drugs, Isosorbide
Dinitrate had the highest incidence of dispense, at an 86%
approved rate of dispense, followed by Enoxaparin at 82%.
The prescription-only drug that had the lowest incidence of
dispense was Codeine, with 4% approved rate of dispense, fol-
lowed by Ciprofloxacin at a 57% approved rate of dispense
(Fig. 3). Collectively, these results illustrate an alarming rate
of dispense of prescription-only medications in Saudi Arabia.
The same medication requests were made to pharmacy
departments in governmental hospitals in each of the investi-Figure 2 Prescription-only medications approved dispense rate in 6
and per medication. The percentage of approved or rejected dispense
region. Bars represent the percentage of approved dispense only.
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requests were rejected in the absence of valid prescriptions,
demonstrating that laws and work ethics are well observed in
the governmental settings. While there are many explanations
for the observed violations of drug dispensing laws, ﬁnancial
gain cannot be ruled out as the main reason.
5. Discussion
Non-compliance to the pharmaceutical law governing dispense
of prescription-only medications is a common malpractice in
Saudi Arabia and other developing countries (Sabry et al.,
2014; Al-Mohamadi et al., 2013). Such practices do not only
reﬂect the pharmacist’s misconduct, but it also puts a patient’s
life in danger (Khan, 2014).
While a number of studies have previously investigated the
dispensing malpractice in conﬁned cities in Saudi Arabia, the
present study, however, is the ﬁrst of its kind to rather assess
pharmacy compliance over six major cities in Saudi Arabia.
In the current study we assessed the community pharmacy
compliance with dispensing regulations that prohibit the dis-
pensing of medications in the absence of a physician
prescription.
The profession of pharmacy mandates a pharmacist to
comply with international ethical standards of care and it
holds the pharmacist responsible for malpractice (Sveska,
1993). A study by Bawazir and colleagues more than two dec-
ades ago, reported that more than 35% of medications dis-
pensed without prescription in Saudi Arabia were
prescription only drugs [SA Bawazir, 1992]. More recently, a
study conducted in the region of Riyadh reported 49% of
the medications being dispensed was prescription-only
(Aljadhey et al., 2015), indicating an unfavorable increase in
the malpractice over a period of more than 20 years.
The rate of non-compliance across community pharmacies
in Saudi Arabia is alarming; however, the extent ofmajor regions in Saudi Arabia. Pharmacies were scored per region
was calculated based on the number of pharmacies surveyed per
he rate and prevalence of dispensing high-risk prescription-only medications at
://dx.doi.org/10.1016/j.jsps.2016.10.001
Drug Approved Rejected 
Warfarin 65% 35% 
Verapamil 70% 30% 
Nitroglycrin 74% 26% 
Enoxparin 82% 18% 
Isosorbid Dinitrate 86% 14% 
Methyldopa 64% 36% 
Propranolol 73% 27% 
Digoxin 59% 41% 
Ciprofloxacin 57% 43% 
Codeine 4% 96% 
Figure 3 Incidence of dispense for prescription-only medications in Saudi Arabia. Incidence of dispense was calculated per medication.
The average of approved dispense per medication was calculated from the 6 regions as well as the average of the rejected dispense per
medication. Statistical analysis was performed between the groups and a signiﬁcant difference between approved and rejected rates was
calculated (p= 0.09).
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ications has not been thoroughly investigated. We report that
the non-compliance rate with dispense of prescription-only
medications across 150 community pharmacies across 6
regions in Saudi Arabia is as high as 63%, a rate of appreciable
concern.
The relatively narrow therapeutic index of digoxin and war-
farin makes them toxic without appropriate use (Tatlisu et al.,
2015; Alquwaizani et al., 2013). Digitalis toxicity is a well-
documented problem for many years due to their narrow ther-
apeutic index, and thus prescription of digoxin usually requires
through estimation of renal and hepatic functions as well as
close monitoring (Kanji and MacLean, 2012; Tatlisu et al.,
2015). However, surprisingly the rate of approved dispense
for digoxin in community pharmacies without a valid prescrip-
tion is as high as 59%. Warfarin adverse effects hospitalization
accounts for 33.3% of hospitalized cases (Budnitz et al., 2011),
yet the approved dispense rate across community pharmacies
in Saudi Arabia is at a high of 63%. Additionally, having
prescription-only drugs with narrow therapeutic indices read-Please cite this article in press as: Alshammari, T.M. et al., Pharmacy Malpractice: T
community pharmacies in Saudi Arabia. Saudi Pharmaceutical Journal (2016), http:ily dispensed will likely increase hospital related visits due to
potential overdose or toxicity. Although 66.6% of pharmacists
in a previous study perceived unwanted professional behavior
about controlled drugs, as an ethical problem (Al-Ariﬁ, 2014),
it is intriguing that the rate of non-compliance is well above
65% with the vast majority of the prescription-only medica-
tions surveyed in the current study.
The likely outcome for patients of non-complied pharma-
cists includes increased risks of adverse drug reaction and its
consequences such as death, reduced functional abilities or
long-term disability that may require use of medical resources
such as nursing homes, hospital visits and hospital admissions,
which as a result increases the health cost and expenditure (Col
et al., 1990; Sullivan et al., 1990). Reports of Chronic Obstruc-
tive Pulmonary Disease patients indicated that poor adherence
to drug therapy and disease management leads to emergency
hospitalization (Fuso et al., 1995). Dispensing malpractice
can also be viewed as an ethical issue, where privately run
pharmacies demonstrated their preference of ﬁnancial gain
over patient’s safety. Dispensing malpractice does not onlyhe rate and prevalence of dispensing high-risk prescription-only medications at
//dx.doi.org/10.1016/j.jsps.2016.10.001
6 T.M. Alshammari et al.affect the patients, but also the provider, the physician and the
signiﬁcant healthcare consequences that dispensing malprac-
tice possesses, makes it an imperative public health concern.
In conclusion, dispensing malpractice remains a major
threat to public health. The vast majority of pharmacists do
not adhere to the law that governs dispense of prescription-
only medications, thus neglecting the harms that such practices
would cause to the community. We suggest that in addition to
the necessity of establishing a code of ethics for pharmacists in
Saudi Arabia (Al-Ariﬁ, 2014), a close and constant monitoring
of pharmacies by the responsible authority ﬁgures such as the
Saudi FDA and the Ministry of Health will minimize and
reduce potential misconduct. Also, the authorities should pro-
vide further education and training for pharmacists to empha-
size the potential devastating and detrimental consequences of
negligence in pharmacy practice to the public health.
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